Literature DB >> 1415757

Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats.

T Nagao1, S Illiano, P M Vanhoutte.   

Abstract

Endothelium-dependent relaxations that are resistant to inhibitors of nitric oxide synthase probably are mediated by endothelium-dependent hyperpolarization of the vascular smooth muscle. Experiments were performed to examine the distribution of this type of relaxation along the arterial tree of the rat by measuring changes in isometric force. Acetylcholine induced concentration- and endothelium-dependent relaxations in aortas and in pulmonary, common iliac, femoral, mesenteric, and renal arteries contracted with phenylephrine. In the presence of NG-nitro-L-arginine, the cumulative administration of acetylcholine induced relaxations only in the femoral, mesenteric, and renal arteries. The calcium ionophore A23187 relaxed mesenteric arteries contracted with phenylephrine in a concentration- and endothelium-dependent manner. The concentration-relaxation curve to A23187 was shifted to the right in the presence of NG-nitro-L-arginine. The maximal relaxations induced by lemakalim, a K+ channel opener, were smaller in those arteries that did not exhibit NG-nitro-L-arginine-resistant relaxations. These results suggest that NG-nitro-L-arginine-resistant relaxations are more frequently observed in smaller arteries. The arteries that exhibit NG-nitro-L-arginine-resistant relaxations may be more sensitive to an endothelium-derived substance that causes hyperpolarization of vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415757     DOI: 10.1152/ajpheart.1992.263.4.H1090

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  46 in total

Review 1.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

2.  Characteristics of ACh-induced hyperpolarization and relaxation in rabbit jugular vein.

Authors:  Takeo Itoh; Takashi Maekawa; Yasushi Shibayama
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

3.  EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries.

Authors:  M Tare; H C Parkington; H A Coleman
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Acute activation of endothelial AMPK surprisingly inhibits endothelium-dependent hyperpolarization-like relaxations in rat mesenteric arteries.

Authors:  Hui Chen; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2019-07-04       Impact factor: 8.739

5.  Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels.

Authors:  Asif K Mustafa; Gautam Sikka; Sadia K Gazi; Jochen Steppan; Sung M Jung; Anil K Bhunia; Viachaslau M Barodka; Farah K Gazi; Roxanne K Barrow; Rui Wang; L Mario Amzel; Dan E Berkowitz; Solomon H Snyder
Journal:  Circ Res       Date:  2011-10-06       Impact factor: 17.367

Review 6.  Modulation of T-type calcium channels by bioactive lipids.

Authors:  Jean Chemin; Magali Cazade; Philippe Lory
Journal:  Pflugers Arch       Date:  2014-02-16       Impact factor: 3.657

7.  Endothelium-derived hyperpolarizing factor in the brain: influence of sex, vessel size and disease state.

Authors:  Catherine M Davis; Dominic A Siler; Nabil J Alkayed
Journal:  Womens Health (Lond)       Date:  2011-05

8.  5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.

Authors:  Magali Cazade; Isabelle Bidaud; Pernille B Hansen; Philippe Lory; Jean Chemin
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

9.  Multiple pathways underlying endothelium-dependent relaxation in the rabbit isolated femoral artery.

Authors:  F Plane; T Pearson; C J Garland
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 10.  Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.

Authors:  William B Campbell; Kathryn M Gauthier
Journal:  J Cardiovasc Pharmacol       Date:  2013-03       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.